Search Results 881-890 of 14757 for anti-TNF drugs

1. Levonorgestrel And Ethinyl Estradiol (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Alesse; Alesse-28; Altavera; Amethia ...

2. Mayo Clinic Comprehensive Cancer Center Research

   ... anti-PD-1 antibody blockade enhances anti-tumor activity in glioblastoma treatment; Demonstrating that intraperitoneal administration of measles virus-sodium ...

3. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

   Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

4. Paclitaxel (Intravenous Route) Precautions - Mayo Clinic

   Cancer medicines can cause diarrhea, nausea, or vomiting in most people, sometimes even after receiving medicines to prevent it. Ask your doctor or nurse about ...

5. Serdexmethylphenidate And Dexmethylphenidate (Oral Route) Description and Brand Names - Mayo Clinic

   Serdexmethylphenidate and dexmethylphenidate combination is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines ...

6. Sodium Thiosulfate (Intravenous Route) Description and Brand Names - Mayo Clinic

   Sodium thiosulfate is also used to reduce the risk of hearing loss in children 1 month of age and older who are receiving medicines (eg, cisplatin) for ...

7. Ethinyl Estradiol And Etonogestrel (Vaginal Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. NuvaRing. Descriptions. Etonogestrel and ethinyl ...

8. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Patients who were previously exposed to tumor necrosis factor (TNF) ...

9. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

   Patients who have received infliximab, adalimumab or certolizumab pegol ≤ 8 weeks before the first administration of study drug; Patients with certain ...

10. Antifibrotics may extend lives for patients with IPF - Mayo Clinic News Network

    Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of ...